OZMOSI and Planview partner to enhance pharmaceutical data integration
The integration aims to ensure planning is based on real-world clinical developments, uniting internal and external insights.
Drug Development
Cumberland to sell drug portfolio to Apotex for $100m
Sanofi receives FDA approval for Tzield in paediatric diabetes
MSD teams up with Google Cloud on agentic AI transformation
BioAegis and Prenosis partner for inflammatory disease therapies
Health Canada approves Biocon’s two denosumab biosimilars
Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy
Asahi Kasei acquires German company Aicuris
